These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22669454)

  • 21. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
    Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
    Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of a solid component in pulmonary adenocarcinoma.
    Ohtaki Y; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Takeyoshi I; Nagai K
    Ann Thorac Surg; 2011 Apr; 91(4):1051-7. PubMed ID: 21440121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.
    Yoshiya T; Mimae T; Tsutani Y; Tsubokawa N; Sasada S; Miyata Y; Kushitani K; Takeshima Y; Murakami S; Ito H; Nakayama H; Okada M
    Ann Thorac Surg; 2016 Nov; 102(5):1668-1673. PubMed ID: 27344277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Chen Z; Liu X; Zhao J; Yang H; Teng X
    Int J Clin Exp Pathol; 2014; 7(11):8039-45. PubMed ID: 25550848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma.
    Maeda R; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2011 Apr; 6(4):743-50. PubMed ID: 21325977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
    Hata K; Yoshida J; Udagawa H; Hashimoto H; Fujii S; Hishida T; Kuwata T; Aokage K; Kojima M; Ochiai A; Suzuki K; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1421-30. PubMed ID: 27059464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
    Sica G; Yoshizawa A; Sima CS; Azzoli CG; Downey RJ; Rusch VW; Travis WD; Moreira AL
    Am J Surg Pathol; 2010 Aug; 34(8):1155-62. PubMed ID: 20551825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator.
    Maeshima AM; Tochigi N; Yoshida A; Asamura H; Tsuta K; Tsuda H
    J Thorac Oncol; 2010 Mar; 5(3):333-9. PubMed ID: 20125041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive adenocarcinomas of the lung.
    Dacic S
    Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiologic implications of the 2011 classification of adenocarcinoma of the lung.
    Austin JH; Garg K; Aberle D; Yankelevitz D; Kuriyama K; Lee HJ; Brambilla E; Travis WD
    Radiology; 2013 Jan; 266(1):62-71. PubMed ID: 23070271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
    Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
    Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma.
    Tomita M; Ayabe T; Chosa E; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(9):3857-60. PubMed ID: 25987049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.
    Maeshima AM; Niki T; Maeshima A; Yamada T; Kondo H; Matsuno Y
    Cancer; 2002 Dec; 95(12):2546-54. PubMed ID: 12467069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistopathological re-evaluation of adenocarcinoma of the lung with mixed subtypes using a tissue microarray technique and hierarchical clustering analysis.
    Gamal G; Sano T; Sakurai S; Kawashima O; Sugano M; Nakajima T
    Pathol Int; 2007 Dec; 57(12):765-74. PubMed ID: 17988277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrally located adenocarcinoma with endobronchial polypoid growth: clinicopathological analysis of five cases.
    Hishida T; Ishii G; Kodama T; Tsuta K; Nara M; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Pathol Int; 2011 Feb; 61(2):73-9. PubMed ID: 21255183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.